130 related articles for article (PubMed ID: 28108675)
1. Paired assessment of liver telomere lengths in hepatocellular cancer is a reliable predictor of disease persistence.
Feng W; Yu D; Li B; Luo OY; Xu T; Cao Y; Ding Y
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28108675
[TBL] [Abstract][Full Text] [Related]
2. Association of telomere length in peripheral leukocytes with chronic hepatitis B and hepatocellular carcinoma.
Ma Q; Cai J; Cai Y; Xu Y; Chang F; Xu L; Zhang G; Guo X
Medicine (Baltimore); 2016 Sep; 95(39):e4970. PubMed ID: 27684844
[TBL] [Abstract][Full Text] [Related]
3. Effect of occult hepatitis B virus infection on the early-onset of hepatocellular carcinoma in patients with hepatitis C virus infection.
Nakano M; Kawaguchi T; Nakamoto S; Kawaguchi A; Kanda T; Imazeki F; Kuromatsu R; Sumie S; Satani M; Yamada S; Torimura T; Kakuma T; Yokosuka O; Sata M
Oncol Rep; 2013 Nov; 30(5):2049-55. PubMed ID: 23982634
[TBL] [Abstract][Full Text] [Related]
4. Influence of hepatitis C virus infection on circulating levels of sICAM-1 and VEGF in patients with hepatitis C and hepatocellular carcinoma (HCC) and their role in enhancing detection of HCC.
Helaly GF; Abou Shamaa LA
Egypt J Immunol; 2006; 13(1):27-38. PubMed ID: 17974148
[TBL] [Abstract][Full Text] [Related]
5. Prospective and longitudinal evaluations of telomere length of circulating DNA as a risk predictor of hepatocellular carcinoma in HBV patients.
Wan S; Hann HW; Ye Z; Hann RS; Lai Y; Wang C; Li L; Myers RE; Li B; Xing J; Yang H
Carcinogenesis; 2017 Apr; 38(4):439-446. PubMed ID: 28334112
[TBL] [Abstract][Full Text] [Related]
6. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
[TBL] [Abstract][Full Text] [Related]
7. Differential association of STAT3 and HK-II expression in hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma.
Li M; Wang W; Jin R; Zhang T; Li N; Han Q; Wei P; Liu Z
J Med Virol; 2016 Sep; 88(9):1552-9. PubMed ID: 26889748
[TBL] [Abstract][Full Text] [Related]
8. Genetic association of telomere length with hepatocellular carcinoma risk: A Mendelian randomization analysis.
Cheng Y; Yu C; Huang M; Du F; Song C; Ma Z; Zhai X; Yang Y; Liu J; Bei JX; Jia W; Jin G; Li S; Zhou W; Liu J; Dai J; Hu Z
Cancer Epidemiol; 2017 Oct; 50(Pt A):39-45. PubMed ID: 28797893
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of HBV and HCV infection in Japanese patients with hepatocellular carcinoma.
Suga M; Senota A; Arima K; Kodama T; Ikuta S; Sakamoto H; Ohe Y; Sugai S; Yachi A
Hepatogastroenterology; 1994 Oct; 41(5):438-41. PubMed ID: 7531667
[TBL] [Abstract][Full Text] [Related]
10. Higher Ratio of Serum Alpha-Fetoprotein Could Predict Outcomes in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma and Normal Alanine Aminotransferase.
Kim YI; Kim HS; Park JW
PLoS One; 2016; 11(6):e0157299. PubMed ID: 27304617
[TBL] [Abstract][Full Text] [Related]
11. Telomere changes in human hepatocellular carcinomas and hepatitis virus infected noncancerous livers.
Ohashi K; Tsutsumi M; Nakajima Y; Kobitsu K; Nakano H; Konishi Y
Cancer; 1996 Apr; 77(8 Suppl):1747-51. PubMed ID: 8608573
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance.
Ismail MM; Morsi HK; Abdulateef NA; Noaman MK; Abou El-Ella GA
Scand J Clin Lab Invest; 2017 May; 77(3):175-183. PubMed ID: 28276727
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis virus infection affects DNA methylation in mice with humanized livers.
Okamoto Y; Shinjo K; Shimizu Y; Sano T; Yamao K; Gao W; Fujii M; Osada H; Sekido Y; Murakami S; Tanaka Y; Joh T; Sato S; Takahashi S; Wakita T; Zhu J; Issa JP; Kondo Y
Gastroenterology; 2014 Feb; 146(2):562-72. PubMed ID: 24184133
[TBL] [Abstract][Full Text] [Related]
14. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma.
Li LM; Hu ZB; Zhou ZX; Chen X; Liu FY; Zhang JF; Shen HB; Zhang CY; Zen K
Cancer Res; 2010 Dec; 70(23):9798-807. PubMed ID: 21098710
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of viral protein interaction networks in Hepatitis B virus and Hepatitis C virus infected HCC.
Yuan W; Huang T; Yu J; Zeng L; Lian B; He Q; Li Y; Zhang X; Zhou F; Xie L
Biochim Biophys Acta; 2014 Jan; 1844(1 Pt B):271-9. PubMed ID: 23774196
[TBL] [Abstract][Full Text] [Related]
16. Relative telomere length: a novel non-invasive biomarker for the risk of non-cirrhotic hepatocellular carcinoma in patients with chronic hepatitis B infection.
Fu X; Wan S; Hann HW; Myers RE; Hann RS; Au J; Chen B; Xing J; Yang H
Eur J Cancer; 2012 May; 48(7):1014-22. PubMed ID: 22444598
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus-related hepatocellular carcinoma and liver cirrhosis.
Pecic V; Stankovic-Djordjevic D; Nestorovic M; Radojkovic M; Marjanovic H; Ilic B; Milojkovic M
J BUON; 2011; 16(2):277-81. PubMed ID: 21766498
[TBL] [Abstract][Full Text] [Related]
18. Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis.
Miura N; Horikawa I; Nishimoto A; Ohmura H; Ito H; Hirohashi S; Shay JW; Oshimura M
Cancer Genet Cytogenet; 1997 Jan; 93(1):56-62. PubMed ID: 9062581
[TBL] [Abstract][Full Text] [Related]
19. Telomere Length and Risk of Hepatocellular Carcinoma: A Nested Case-control Study in Taiwan Cancer Screening Program Cohort.
Zeng H; Wu HC; Wang Q; Yang HI; Chen CJ; Santella RM; Shen J
Anticancer Res; 2017 Feb; 37(2):637-644. PubMed ID: 28179311
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of hepatocellular carcinoma incidence in thalassemia.
Mancuso A; Sciarrino E; Renda MC; Maggio A
Hemoglobin; 2006; 30(1):119-24. PubMed ID: 16540424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
